FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

PhRMA Suggests REMS Guidance Changes

[ Price : $8.95]

PhRMA says FDA should refine its approach to REMS requirements.

Mayo PET Facility Asks F-18 FDG Change

[ Price : $8.95]

Mayo Clinics PET facility asks FDA to change the highest strength of a reference-listed drug used in imaging studies.

FDA Refuses to File Genentech Breast Cancer BLA

[ Price : $8.95]

FDA sends Genentech a refuse-to-file letter on its BLA for trastuzumab-DM1 (T-DM1), seeking accelerated approval for treating brea...

FDA Approves NDA for Tekamlo

[ Price : $8.95]

FDA approves a Novartis NDA for Tekamlo (aliskiren and amlodipine) tablets, a combination pill for treating high blood pressure.

Animal Drug Sponsor Changes Recorded

[ Price : $8.95]

Federal Register Final rule: FDA amends the animal drug regulations to reflect change of sponsor for a NADA from Peptech Animal He...

FDA Withdraws Two Worming Capsule NADAs

[ Price : $8.95]

Federal Register Notice: FDA withdraws approval of 2 Pegasus Labs NADAs for Tiny Tiger Worming Capsules and LK Worming Capsules.

FDA Clears SonoSite Lumen Catheter System

[ Price : $8.95]

FDA clears a SonoSite 510(k)for the LumenVu Catheter Guidance System.

Multi-Med Huber Needles are Class 1 Recall

[ Price : $8.95]

FDA announces a Class 1 recall of certain lots of Multi-Med, Inc. Huber needles that were found to core or remove silicone slivers...

Wolfe vs Rappaport Flap Exposes FDA Communication Problem

[ Price : $8.95]

An unusual exchange last week at an advisory committee meeting between Public Citizens Health Research Group director Sidney Wolfe...

Stryker Settles Mass. Suit for $1.35 Million

[ Price : $8.95]

Stryker agrees to pay $1.35 million to settle a Massachusetts fraudulent marketing suit.